Artificial Intelligence (AI) made retinal imaging 100 times faster, compared to manual method
On Apr. 10, 2024, researchers at the National Institutes of Health (NIH) applied artificial intelligence (AI) to a…
On Apr. 10, 2024, researchers at the National Institutes of Health (NIH) applied artificial intelligence (AI) to a…
On Apr. 7, 2024, Edwards Lifesciences announced the release of data from the HUDDLE study that examined the…
On Mar. 27, 2024, researchers from Trinity College Dublin announced they had recovered remarkably preserved microbiomes from two…
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
On Mar. 21, 2024, the U.S. Food and Drug Administration (FDA) approved Italfarmaco’s Duvyzat (givinostat) oral medication for…
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
On Mar. 18, 2024, the U.S. Food and Drug Administration (FDA) approved Orchard Therapeutics’ Lenmeldy (atidarsagene autotemcel), the…
On Mar. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the…
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Mar. 5, 2024, the U.S. Food and Drug Administration (FDA) cleared for marketing the first over-the-counter (OTC)…
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative…
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
On Feb. 16, 2024, Regeneron and Sanofi announced that the Ministry of Health, Labor and Welfare (MHLW) in…
On Feb. 2, 2024, Chinese scientists announced they have assembled the world’s most detailed human genome yet, a…
On Jan. 27, 2024, the National Health Commission of the People’s Republic of China notified the World Health…
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
On Jan. 24, 2024, Oregon Health & Science University announced that Pamela Runner, 77, of Corvallis, became the…
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…
On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
On Dec. 14, 2023, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announced that it had…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenメs Health Research, an effort led…
On Oct. 31, 2023, the U.S. Food and Drug Administration (FDA) announced it had approved Amgen’s Wezlana (ustekinumab-auub)…